T1008 Insulin Sensitizers for the Management of Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials

2009 ◽  
Vol 136 (5) ◽  
pp. A-845
Author(s):  
Abhishek Choudhary ◽  
Nicholas M. Szary ◽  
Matthew L. Bechtold ◽  
Srinivas R. Puli ◽  
Scott Rector ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver ◽  
Randomized Controlled Trials ◽  
Fatty Liver Disease ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Alcoholic Fatty Liver ◽  
Randomized Controlled ◽  
Insulin Sensitizers ◽  
Alcoholic Fatty Liver Disease

Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

2020 ◽  
Vol 11 (9) ◽  
pp. 7389-7399
Author(s):  
Xiao-fei Guo ◽  
Chong Wang ◽  
Ting Yang ◽  
Shan Li ◽  
Ke-lei Li ◽  
...  
Keyword(s):  
Vitamin D ◽  
Liver Disease ◽  
Fatty Liver ◽  
Randomized Controlled Trials ◽  
Fatty Liver Disease ◽  
Meta Analysis ◽  
Controlled Trials ◽  
Alcoholic Fatty Liver ◽  
Randomized Controlled ◽  
Alcoholic Fatty Liver Disease

The results of randomized controlled trials (RCTs) investigating supplemental vitamin D on aminotransferases and cardio-metabolic risk factors in subjects with non-alcoholic fatty liver disease (NAFLD) have been inconsistent.

Sign in / Sign up

Export Citation Format

Share Document